Evidence map›Paper›PMID 33212422›Full record

ArticleBreast (Edinburgh, Scotland)2020

Prevalence, trend and disparities of palliative care utilization among hospitalized metastatic breast cancer patients who received critical care therapies.

Ying Chen, Shuchen Lin, Yihui Zhu, Rui Xu, Xiaohong Lan, Fang Xiang, Xiang Li, Ye Zhang, Shudong Chen, Hao Yu and 8 more

Open access · goldAbstract readEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Breast (Edinburgh, Scotland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Impact of the implementation of an embedded palliative care model in the continuum of care for patients with metastatic breast cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Ying ChenDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Department of Pharmacy, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Shuchen LinDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Yihui ZhuDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Rui XuDepartment of Pharmacy, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Xiaohong LanDepartment of Pharmacy, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Fang XiangDepartment of Pharmacy, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Xiang LiDepartment of Pharmacy, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Ye ZhangDepartment of Pharmacy, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Shudong ChenDepartment of Pharmacy, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Hao YuDepartment of Pharmacy, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Dongni WuDepartment of Pharmacy, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Juxiang ZangDepartment of Pharmacy, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Jiali TangDepartment of Pharmacy, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Jiewen JinDepartment of Endocrinology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Hedong HanDepartment of Health Statistics, Second Military Medical University, Shanghai, 200433, China.
Zhonghua TaoDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: drtaozhh@126.com.
Yonggang ZhouDepartment of Pharmacy, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China. Electronic address: zhouyang1300@126.com.
Xichun HuDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: huxichun2019@163.com.
Nanjing General Hospital of Nanjing Military Command · CNShanghai Medical College of Fudan University · CNSecond Military Medical University · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly integration of palliative care (PC) for patients with advanced cancer has been recommended to improve quality of care. This study aims to describe prevalence, temporal trend and predictors of PC use in metastatic breast cancer (mBCa) patients receiving critical care therapies (CCT; included invasive mechanic ventilation, percutaneous endoscopic gastrostomy tube, total parenteral nutrition, tracheostomy and dialysis).

methodsThe National Inpatient Sample was queried for mBCa patients receiving CCT between 2005 and 2014. Annual percent changes (APC) were calculated for PC prevalence in the overall cohort and subgroups. Multivariable logistic analysis was used to explore predictors of PC use.

resultsOf 5833 mBCa patients receiving CCT, 880 (15.09%) received PC. Rate of PC use increased significantly from 2.53% in 2005 to 25.96% in 2014 (APC: 35.75%; p < 0.0001). Higher increase in PC use was observed in South (from 0.65% to 27.11%; APC: 59.42%; p < 0.0001), medium bedsize hospitals (from 3.75% to 26.05%; APC: 38.16%; p = 0.0006) and urban teaching hospitals (from 4.13% to 29.86%; APC: 37.33%; p = 0.0005). Multivariable analysis revealed that year interval, urban teaching hospitals, and invasive mechanical ventilation were associated with increased PC use, while primary diagnosis of gastrointestinal disorders, fractures, metastatic sites from lymph nodes and tracheostomy were associated with lower PC use.

conclusionsPC use in mBCa patients receiving CCT increases significantly over the period. However, it still remains low. Efforts to illustrate disparities in PC use are needed to improve quality of care for mBCa patients receiving CCT, especially for those hospitalized in rural and nonteaching hospitals.

Indexed as

AgedBreast NeoplasmsCritical CareDatabases, FactualFemaleHealthcare DisparitiesHumansInpatientsLogistic ModelsMiddle AgedPalliative CarePatient Acceptance of Health CarePrevalenceQuality of Health CareUnited StatesDisparitiesInpatientMetastatic breast cancerPalliative care

Identifiers

PMID33212422
PMCPMC7679246
OpenAlexW3096752841

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.